智通财经APP获悉，绿叶制药(02186)跌超9%，截至发稿，跌9.62%，报1.925港元，成交额1.44亿港元。
消息面上，绿叶制药发布2026年中期业绩，上半年公司收入为30.02亿元，同比减少5.6%；毛利减少至19.02亿元，毛利率为63.4%，同比下降11.8%；股东应占溢利为3.91亿元，增长24.8%。业务表现看，其传统的肿瘤业务承压明显，2026年上半年肿瘤治疗领域的收入为8.36亿元，同比下降35.5%。
截至2026年6月末，绿叶集团合计计息贷款及借款达103.01亿元，较2025年末的83.52亿元显著抬升；资产负债率（总借款/总权益）由45.5%攀升至58.6%。一年以内到期有息负债高达91.62亿元，短期偿债压力较重。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.